PRO-DEX, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PRO-DEX, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2023-03-31 was 0.00 shares.
- PRO-DEX, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-12-31 was 1.50K shares.
- PRO-DEX, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-09-30 was 5.00K shares, a 80.00% decline year-over-year.
- PRO-DEX, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-03-31 was 0.00 shares.
- PRO-DEX, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2019 was 3.00K shares.
- PRO-DEX, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2017 was 33.83K shares, a 351.12% increase from fiscal 2016.
- PRO-DEX, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2016 was 7.50K shares.
- PRO-DEX, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2015 was -48.33K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2023-03-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-04 | |
| 2022-12-31 | 1.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-02 | |
| 2022-09-30 | 5.00K shares 10-Q · filed 2022-11-03 | |
| 2022-03-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-04 | |
| 2021-12-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-02 | |
| 2021-09-30 | 25.00K shares 10-Q · filed 2022-11-03 | |
| 2021-03-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-05 | |
| 2020-12-31 | 2.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-03 | |
| 2020-09-30 | 20.00K shares 10-Q · filed 2021-11-15 | |
| 2019-06-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-10 | 3.00K shares 10-K · filed 2020-09-10 |
| 2019-03-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-07 | |
| 2017-06-30 | 5.83K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-13 | 33.83K shares 10-K · filed 2018-09-13 |
| 2017-03-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-10 | 43.00K shares derived: sum of 4 quarters · filed 2018-05-10 |
| 2016-12-31 | 3.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-08 | 43.00K shares derived: sum of 4 quarters · filed 2018-02-08 |
| 2016-09-30 | 25.00K shares 10-Q · filed 2017-11-09 | |
| 2016-06-30 | 15.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-14 | 7.50K shares 10-K · filed 2017-09-14 |
| 2016-03-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-11 | |
| 2015-06-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-15 | -48.33K shares 10-K · filed 2016-09-15 |
| 2014-06-30 | 591.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-17 | -4.10K shares 10-K · filed 2015-09-17 |
| 2014-03-31 | -3.89K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-14 | -14.70K shares derived: sum of 4 quarters · filed 2015-05-14 |
| 2013-12-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-10 | -10.80K shares derived: sum of 4 quarters · filed 2015-02-10 |
| 2013-09-30 | -804.00 shares 10-Q · filed 2014-11-13 | -44.14K shares derived: sum of 4 quarters · filed 2014-11-13 |
| 2013-06-30 | -10.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-18 | -43.33K shares 10-K · filed 2014-09-18 |
| 2013-03-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-12 | |
| 2012-12-31 | -33.33K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-06 | |
| 2012-09-30 | 0.00 shares 10-Q · filed 2012-11-08 | |
| 2012-06-30 | -24.72K shares 10-K · filed 2013-09-27 | |
| 2011-09-30 | 0.00 shares 10-Q · filed 2012-11-08 | |
| 2011-06-30 | 20.50K shares 10-K · filed 2012-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |